• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Prostate-specific antigen level association with COVID-19 infection and vaccination
CONCLUSION: SARS-CoV-2 infection and vaccinations are associated with a slight increase in PSA, with the third anti-COVID vaccine dose having a more prominent impact, but its clinical significance is unknown yet. Any significant increase in PSA must be investigated and cannot be dismissed as secondary to SARS-CoV-2 infection or vaccination.PMID:37270370 | PMC:PMC10159928 | DOI:10.1016/j.clgc.2023.05.001
Source: Clinical Prostate Cancer - June 3, 2023 Category: Cancer & Oncology Authors: Michael Frumer Shachar Moshe Aharony Ohad Shoshany Daniel Kedar Jack Baniel Shay Golan Source Type: research

Current thoughts on cellular functions of numb-associated kinases
Mol Biol Rep. 2023 Apr 4:1-8. doi: 10.1007/s11033-023-08372-x. Online ahead of print.ABSTRACTMembers of the Numb-associated kinase family of serine/threonine kinases play an essential role in many cellular processes, such as endocytosis, autophagy, dendrite morphogenesis, osteoblast differentiation, and the regulation of the Notch pathway. Numb-associated kinases have been relevant to diverse diseases, including neuropathic pain, Parkinson's disease, and prostate cancer. Therefore, they are considered potential therapeutic targets. In addition, it is reported that Numb-associated kinases have been involved in the life cycl...
Source: Molecular Biology Reports - April 4, 2023 Category: Molecular Biology Authors: Chenxi Huang Cuicui Ji Juan Wang Source Type: research

Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis
CONCLUSIONS: Only a minority of patients with genitourinary cancers did not ultimately achieve satisfactory seroconversion after receiving commercial COVID-19 vaccination. Cancer type or treatment rendered did not appear to affect the immune response mounted after vaccination.PMID:36971500 | DOI:10.1093/oncolo/oyad067
Source: The Oncologist - March 27, 2023 Category: Cancer & Oncology Authors: Luis Meza Zeynep Zengin Sabrina Salgia Jasnoor Malhotra Ewa Karczewska Tanya Dorff Abhishek Tripathi Jennifer Ely Erin Kelley Heather Mead Jo Ann Hsu Nazli Dizman Nicholas Salgia Neal Chawla Alex Chehrazi-Raffle Ramya Muddasani Ameish Govindarajan Adam Ro Source Type: research

The SARS-COV-2 Seroprevalence among Oncology Patients
J Clin Med. 2023 Jan 9;12(2):529. doi: 10.3390/jcm12020529.ABSTRACTPatients with cancer are presumed to be vulnerable to an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe clinical outcomes due to the immunocompromised state mediated by their underlying malignancies and therapy. The aim of this study was to estimate the SARS-CoV-2 seroprevalence, following second to fourth waves in solid tumour patients attending the Steve Biko Academic Hospital (SBAH) for diagnosis and treatment of cancer. We used the single-prick COVID-19 IgG/IgM Rapid Test Cassettes to detect SARS-CoV-...
Source: Clinical Prostate Cancer - January 21, 2023 Category: Cancer & Oncology Authors: Mankgopo Kgatle Rajesh Das Ismaheel Lawal Tebatso Boshomane Kgomotso Mokoala Cattleya Gaspar Lydia Mbokazi Nonhlanhla Nkambule Veronique Gow Honest Ndlovu Yonwaba Mzizi Joseph Chalwe Jeaneth Diphofa Dinah Mokobodi Nobuhle Gxekwa Lusanda Zongo Tinashe Maph Source Type: research

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
Urol Oncol. 2022 Sep 1:S1078-1439(22)00308-8. doi: 10.1016/j.urolonc.2022.08.014. Online ahead of print.NO ABSTRACTPMID:36272849 | PMC:PMC9433344 | DOI:10.1016/j.urolonc.2022.08.014
Source: Urologic Oncology - October 22, 2022 Category: Urology & Nephrology Authors: Rujittika Mungmunpuntipantip Viroj Wiwanitkit Source Type: research

Pages: 1  2  3  4  5  6